Iswarya raises Rs 350 crore from OrbiMed Asia

The details

• Iswarya has raised Rs 350 crore in a growth investment round.
• The funding comes from global healthcare investor OrbiMed Asia.
• This is the first major funding event detailed in the provided facts.
• The investment marks a significant capital injection for the fertility chain.
• OrbiMed Asia leads this specific growth stage financing deal.
• The company plans to use the funds for strategic expansion.
• This round supports Iswarya's continued growth across its existing network.
• The deal highlights investor confidence in the Indian fertility sector.

The bigger picture

• OrbiMed Asia is a global healthcare investment firm with expertise in health tech.
• The investment signals strong demand for specialized fertility services in India.
• Growth funding allows Iswarya to scale operations without immediate profitability pressure.
• The deal underscores the maturation of the private healthcare investment landscape.
• Expansion into underserved geographies addresses gaps in reproductive healthcare access.

About the business

• Iswarya provides IVF, IUI, and advanced reproductive treatments.
• Services include fertility preservation and comprehensive genetics testing.
• The company operates 85+ centers across eight Indian states.
• It has served over 300,000 couples since its establishment in 1986.
• Dr. Arun Muthuvel serves as Managing Director and founder.
• The business model relies on high-volume clinical service delivery.
• Centers are located in both established and emerging medical hubs.
• The company focuses on patient experience and clinical outcomes.
• Digital capabilities are part of their operational infrastructure strategy.

What happens next

• Opening new centers in existing and underserved markets.
• Investing in clinical infrastructure and digital capabilities.
• Building an embryology talent pipeline.
• Deepening pan-India presence through geographic expansion.

The deal

Type

growth investment

Investors

• OrbiMed Asia (lead) — Global healthcare investment firm led by Dr. Sunny Sharma and Arun Sadhanandham.

Founders

• Dr. Arun Muthuvel, Managing Director
• Dr. Chandralekha, Management Team Member

About Iswarya

Product

based fertility care provider

Same day

• Wheelocity raises over ₹82 crore in Series A2 funding9 July 2026 · Funding · >₹82 Cr
• Hakimo raises $12M growth funding from Zigg Capital9 July 2026 · Funding · $12M
• Nurix AI acquires Verloop.io to expand enterprise AI platform9 July 2026 · Acquisition
• Yolearn.AI launches AI tutoring with pre-seed funding9 July 2026 · Launch · Pre-seed secured
• Fincart launches AI-driven app with new brand identity9 July 2026 · Launch
• Kicksky launches India's first VC-backed SpaceTech accelerator9 July 2026 · Launch

All startup news on 9 July 2026 →